Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadopiclenol vs Gadobenate Dimeglumine for Cardiac MRI in Adult Congenital Heart Disease
NCT06406517Phase 3Completed
- Sponsor
- University of California, San Diego
- Start
- Aug 2024
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gadopiclenol in congenital heart disease (CHD), sponsored by University of California, San Diego. Started Aug 2024; status: completed.
02
Drugs
gadopiclenol
03
Conditions
congenital heart disease (CHD)
Beyond the preview
Go deeper on NCT06406517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06406517.